Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells

Arthritis and Rheumatology

Volumn 66, Issue 9, 2014, Pages 2558-2569

  Roberts, Mustimbo E P ^a,b   Kaminski, Denise ^a,b   Jenks, Scott A ^a,b   Maguire, Craig ^a,b   Ching, Kathryn ^c   Burbelo, Peter D ^c   Iadarola, Michael J ^c   Rosenberg, Alexander ^a,b   Coca, Andreea ^a,b   Anolik, Jennifer ^a,b   Sanz, Iñaki ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN D; MESSENGER RNA; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEMORY CELL; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ADULT; AGED; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN D; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 84907385240     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38734     Document Type: Article

References (50)

1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164: 1275-84. (Pubitemid 38828877)
2. Galvez J, Saiz E, Lopez P, Pina MF, Carrillo A, Nieto A, et al. Diagnostic evaluation and classification criteria in Sjögren's syndrome. Joint Bone Spine 2009;76:44-9.
3. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
4. Rosen A, Casciola-Rosen L. Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit Rev Oral Biol Med 2004;15:156-64.
5. Youinou P, Saraux A, Pers JO. B-lymphocytes govern the pathogenesis of Sjögren's syndrome. Curr Pharm Biotechnol 2012;13: 2071-7.
6. Scofield RH. IL-21 and Sjögren's syndrome. Arthritis Res Ther 2011;13:137.
7. Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002;46:2160-71.
8. Binard A, Le Pottier L, Devauchelle-Pensec V, Saraux A, Youinou P, Pers JO. Is the blood B-cell subset profile diagnostic for Sjögren syndrome? Ann Rheum Dis 2009;68:1447-52.
9. Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM. Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjögren's syndrome. Scand J Immunol 2001;54:421-7. (Pubitemid 32958579)
10. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998;102:938-46. (Pubitemid 28419239)
11. Coca A, Sanz I. B cell depletion in lupus and Sjögren's syndrome: an update. Curr Opin Rheumatol 2009;21:483-8.
12. Coca A, Sanz I. Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 2012;24:451-6.
13. Manjarrez-Orduno N, Quach TD, Sanz I. B cells and immunological tolerance. J Invest Dermatol 2009;129:278-88.
14. Sanz I, Lee FE. B cells as therapeutic targets in SLE. Nat Rev Rheumatol 2010;6:326-37.
15. Ching KH, Burbelo PD, Gonzalez-Begne M, Roberts ME, Coca A, Sanz I, et al. Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjögren's syndrome. J Dent Res 2011;90:445-9.
16. Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001;167:3610-8. (Pubitemid 32916053)
17. Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, et al. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Arthritis Rheum 2004;50: 1897-908. (Pubitemid 38725102)
18. Hansen A, Lipsky PE, Dorner T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007;9:218.
19. Sanz I, Wei C, Lee FE, Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008; 20:67-82.
20. Bohnhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin Immunol 2002;103: 79-88. (Pubitemid 34478423)
21. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 2007;178: 6624-33. (Pubitemid 46717447)
22. Aitchison J. The statistical analysis of compositional data. London: Chapman & Hall; 1986.
23. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004;104:3647-54. (Pubitemid 39564441)
24. Weill JC, Weller S, Reynaud CA. Human marginal zone B cells. Annu Rev Immunol 2009;27:267-85.
25. Ettinger R, Sims GP, Robbins R, Withers D, Fischer RT, Grammer AC, et al. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol 2007;178:2872-82. (Pubitemid 46333165)
26. Song W, Liu C, Seeley-Fallen MK, Miller H, Ketchum C, Upadhyaya A. Actin-mediated feedback loops in B-cell receptor signaling. Immunol Rev 2013;256:177-89.
27. Batista FD, Treanor B, Harwood NE. Visualizing a role for the actin cytoskeleton in the regulation of B-cell activation. Immunol Rev 2010;237:191-204.
28. +phenotype controls T cell-dependent inflammatory responses. Immunity 2008;28:639-50.
29. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011;117:530-41.
30. - [published erratum appears in J Exp Med 2011;208:67, 409, 871]. J Exp Med 2011;208: 67-80.
31. + B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity. Mol Med 2012;18:1003-8.
32. Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P, et al. Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009;182:3540-7.
33. Rodriguez-Bayona B, Ramos-Amaya A, Perez-Venegas J, Rodriguez C, Brieva J. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther 2010;12:R108.
34. Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR, et al Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol 2005;100:1788-95. (Pubitemid 41648435)
35. Di Sabatino A, Rosado MM, Cazzola P, Biancheri P, Tinozzi FP, Laera MR, et al. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab. Inflamm Bowel Dis 2008;14:591-6. (Pubitemid 351742975)
36. Allan LL, Stax AM, Zheng DJ, Chung BK, Kozak FK, Tan R, et al. CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling. J Immunol 2011; 186:5261-72.
37. Li D, Hong A, Lu Q, Gao GF, Jin B, Screaton GR, et al. A novel role of CD1c in regulating CD1d-mediated NKT cell recognition by competitive binding to Ig-like transcript 4. Int Immunol 2012; 24:729-37.
38. Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C. Lipid-antigen presentation by CD1d+ B cells is essential for the maintenance of invariant natural killer T cells. Immunity 2012;36: 477-90.
39. Westerberg LS, Dahlberg C, Baptista M, Moran CJ, Detre C, Keszei M, et al. Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function. Blood 2012;119:3966-74.
40. Doi H, Iyer TK, Carpenter E, Li H, Chang KM, Vonderheide RH, et al. Dysfunctional B-cell activation in cirrhosis due to hepatitis C infection associated with disappearance of CD27+ B-cell population. Hepatology 2012;55:709-19.
41. Devauchelle-Pensec V, Cagnard N, Pers JO, Youinou P, Saraux A, Chiocchia G. Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab. Arthritis Rheum 2010;62:2262-71.
42. Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, et al. Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun 2009;10:285-96.
43. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52:1534-44. (Pubitemid 40663945)
44. Munir M. TRIM proteins: another class of viral victims. Sci Signal 2010;3:jc2.
45. Zhao C, Hsiang TY, Kuo RL, Krug RM. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A 2010;107:2253-8.
46. Divanovic S, Trompette A, Atabani SF, Madan R, Golenbock DT, Visintin A, et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 2005;6:571-8. (Pubitemid 41710727)
47. Nagai Y, Yanagibashi T, Watanabe Y, Ikutani M, Kariyone A, Ohta S, et al. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells. Int Immunol 2012;24: 389-400.
48. Kobayashi T, Takahashi K, Nagai Y, Shibata T, Otani M, Izui S, et al. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice. Int Immunol 2008; 20:881-91. (Pubitemid 351865863)
49. Jonsson R, Theander E, Sjostrom B, Brokstad K, Henriksson G. Autoantibodies present before symptom onset in primary Sjögren syndrome. JAMA 2013;310:1854-5.
50. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33. (Pubitemid 37255038)